BIANCONI, FORTUNATO
 Distribuzione geografica
Continente #
NA - Nord America 4.297
EU - Europa 2.667
AS - Asia 2.283
SA - Sud America 417
Continente sconosciuto - Info sul continente non disponibili 227
AF - Africa 80
OC - Oceania 6
Totale 9.977
Nazione #
US - Stati Uniti d'America 4.129
SG - Singapore 1.044
IT - Italia 564
IE - Irlanda 509
CN - Cina 335
BR - Brasile 319
RU - Federazione Russa 306
HK - Hong Kong 302
UA - Ucraina 301
SE - Svezia 245
VN - Vietnam 224
DE - Germania 184
FR - Francia 152
FI - Finlandia 134
GB - Regno Unito 108
KR - Corea 75
CA - Canada 68
BD - Bangladesh 63
IN - India 51
IQ - Iraq 31
TR - Turchia 31
AR - Argentina 30
PL - Polonia 24
AT - Austria 23
RO - Romania 23
JP - Giappone 21
MX - Messico 21
CR - Costa Rica 20
NL - Olanda 20
ZA - Sudafrica 18
EC - Ecuador 17
CH - Svizzera 15
ID - Indonesia 14
VE - Venezuela 14
BE - Belgio 13
GT - Guatemala 13
PK - Pakistan 12
CO - Colombia 11
ES - Italia 11
MA - Marocco 11
UZ - Uzbekistan 11
TN - Tunisia 10
BO - Bolivia 9
HN - Honduras 9
LB - Libano 9
PH - Filippine 9
SA - Arabia Saudita 8
CW - ???statistics.table.value.countryCode.CW??? 7
CZ - Repubblica Ceca 7
EG - Egitto 7
OM - Oman 7
PR - Porto Rico 7
GR - Grecia 6
JM - Giamaica 6
KE - Kenya 6
PY - Paraguay 6
SN - Senegal 6
SV - El Salvador 6
AL - Albania 5
AU - Australia 5
CL - Cile 5
IL - Israele 5
JO - Giordania 5
NI - Nicaragua 5
NP - Nepal 5
SC - Seychelles 5
DZ - Algeria 4
ET - Etiopia 4
KZ - Kazakistan 4
LT - Lituania 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
BA - Bosnia-Erzegovina 3
MY - Malesia 3
PA - Panama 3
PE - Perù 3
PT - Portogallo 3
UY - Uruguay 3
AM - Armenia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
EU - Europa 2
GP - Guadalupe 2
MZ - Mozambico 2
BH - Bahrain 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BS - Bahamas 1
CD - Congo 1
CM - Camerun 1
CV - Capo Verde 1
DJ - Gibuti 1
HT - Haiti 1
KG - Kirghizistan 1
KW - Kuwait 1
MK - Macedonia 1
MM - Myanmar 1
MT - Malta 1
MU - Mauritius 1
NO - Norvegia 1
Totale 9.752
Città #
Singapore 711
Chandler 528
Dublin 509
Ashburn 393
San Jose 344
Hong Kong 300
San Mateo 210
Perugia 178
Santa Clara 169
Jacksonville 156
Boardman 140
Council Bluffs 123
Moscow 104
Princeton 103
Medford 98
Ann Arbor 97
Beijing 97
Lauterbourg 85
Andover 84
Wilmington 77
Dong Ket 75
Seoul 75
Munich 60
Altamura 59
Dallas 58
Lawrence 58
Los Angeles 55
Ho Chi Minh City 51
New York 50
São Paulo 39
Helsinki 37
The Dalles 36
Des Moines 35
Hanoi 31
Houston 30
Redwood City 27
Phoenix 26
Saint Petersburg 25
Montreal 22
Rome 22
Bucharest 21
Norwalk 20
Tokyo 20
Woodbridge 20
Chicago 19
Piscataway 19
Brooklyn 17
Frankfurt am Main 17
San José 17
Warsaw 17
Chennai 16
North Bergen 16
Redmond 16
Turku 16
Atlanta 15
Falkenstein 15
Milan 15
Nuremberg 15
Toronto 15
Orem 14
Brussels 13
London 13
Mexico City 13
Coccaglio 12
Denver 12
Johannesburg 12
Naples 12
Poplar 11
San Mauro Pascoli 11
Stockholm 11
Caracas 10
Izmir 10
Baghdad 9
Dearborn 9
Rio de Janeiro 9
San Paolo di Civitate 9
Terni 9
Vienna 9
Bologna 8
Den Haag 8
Guatemala City 8
Haiphong 8
Quito 8
Shanghai 8
Guangzhou 7
Guayaquil 7
Willemstad 7
Amsterdam 6
Da Nang 6
Dakar 6
Dhaka 6
Falls Church 6
Istanbul 6
Manchester 6
Marsciano 6
New Delhi 6
Tashkent 6
Tunis 6
Amman 5
Ankara 5
Totale 6.056
Nome #
Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications 207
An Application of Conditional Robust Calibration (CRC) to The Lotka-Volterra Predator-Prey model in computational systems biology: a comparison of two sampling strategies 188
Cancer Registry and information technology: a new management system for integrating Cancer Registry and Oncology Departments 168
I Tumori multipli in Umbria. 145
Prognostic Role of Erbb Family Receptors, Myc and Mitogen-activated Protein Kinase (mapk) In Patients With Early-stage Non Small-cell Lung Cancer 137
Gene identification for risk of relapse in stage I lung adenocarcinoma patients: A combined methodology of gene expression profiling and computational gene network analysis 134
Incidence of multiple primary cancers following respiratory tract cancer in Umbria, Italy. 133
Partecipazione al IV round dello screening citologico nella AUSL 2 dell’Umbria. 131
A New Bayesian Methodology for Nonlinear Model Calibration in Computational Systems Biology 131
A Hybrid Model of Nucleotide Excision Repair in Neoplastic Diseases: The Identification Problem. 130
Effectiveness and predictability of pleurodesis with the Tachosil® surgical patch compared with talc poudrage: An experimental study 129
Significato prognostico dell’espressione immunoistochimica di Insulin like growth facor receptor 1 (IGFR-1) ed epidermal growth factor receptor (EGFR) nei carcinomi non a piccole cellule del polmone (NSCLC). 128
A Hybrid Model of Nucleotide Excision Repair in Neoplastic diseases and in vitro Experiments 127
Cancer incidence in Italian contaminated sites 127
A machine learning approach applied to Reverse Phase Protein Microarray data for pathways activation mapping of KRAS wild type and mutated adenocarcinomas of the lung 127
P-126 * PROGNOSTIC SIGNIFICANCE OF MYC AND HUMAN TELOMERASE GENE AMPLIFICATION IN SURGICALLY TREATED EARLY STAGE NON-SMALL CELL LUNG CANCER 126
MYC and Human Telomerase Gene (TERC) Copy Number Gain in Early-stage Non-small Cell Lung Cancer 123
Spatial barriers impact upon appropriate delivery of radiotherapy in breast cancer patients 122
Concomitant high gene copy number and protein overexpression of IGF1R and EGFR negatively affect disease-free survival of surgically resected non-small-cell-lung cancer patients 122
Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer 121
Come misurare “l’impatto” dello screening colorettale nella Regione Umbria 121
Cancer burden trends in Umbria region using a joinpoint regression 119
Higher tlr7 gene expression predicts poor clinical outcome in advanced nsclc patients treated with immunotherapy 119
Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of KRAS, PIK3CA, MET, and non-sensitizing EGFR mutations. 117
EPIDEMIOLOGIA DEL CANCRO DELL'ENDOMETRIO IN UMBRIA 115
Robust Calibration of High Dimension Nonlinear Dynamical Models for Omics Data: An Application in Cancer Systems Biology 112
Information technology as tools for Cancer Registry and Regional Cancer Network integration 110
Impact of Epidermal Growth Factor Receptor and KRAS Mutations on Clinical Outcome in Resected Non-Small Cell Lung Cancer Patients 110
I tumori del rene 107
An approach for optimally extending mathematical models of signaling networks using omics data 107
I tumori dell'ovaio. 106
High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer Patients 106
A strategy for parameter estimation for mRNA and protein dynamics 105
Effect of healthcare on mortality: trends in avoidable mortality in Umbria, Italy, 1994-2009 105
Prognostic implication of aquaporin 1 overexpression in resected lung adenocarcinoma 105
Reverse phase protein array (RPPA) combined with computational analysis to unravel relevant prognostic factors in non- small cell lung cancer (NSCLC): a pilot study 105
I tumori della tiroide 103
Screening for colorectal cancer in Italy: 2011-2012 survey 103
High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free servival in resected non-small-cell lung cancer patients. 102
An approach to the conditional robustness problem for biochemical networks 102
Regional indices of socio-economic and health inequalities: a tool for public health programming 102
Stadio alla diagnosi e controllo del cancro del grosso intestino in Umbria. 100
Espressione dei recettori HER nei carcinomi non a piccole cellule del polmone 100
Prognostic implications of epidermal growth factor receptor, KRAS and BRAF gene mutations in resected non-small cell lung cancer patients 99
Co-expression of receptors of the HER family correlates with clinical outcome in non-small cell lung cancer (NSCLC). 98
Computational model of EGFR and IGF1R pathways in lung cancer: A Systems Biology approach for Translational Oncology 98
Registro Tumori, tecnologia informatica e rete oncologica regionale. Integrazione tra Registro Tumori e Servizi oncologici in Umbria. 97
Role of Expression Levels of Fabp3, H19, Tfpi2, Ark1b1 Cyp3a5, Scgb3a2 Genes In Adenocarcinoma Stage I Patients. 96
THE EVOLVING ROLE OF CANCER REGISTRY: INFORMATION TECHNOLOGY AS TOOL FOR INTEGRATION WITH ONCOLOGY DEPARTMENTS 95
Modelli dinamici per lo studio dei meccanismi di riparo del danno al DNA 94
I tumori delle alte vie aero-digestive. 94
EGFR, KRAS, PIK3CA mutations and response to tyrosine kinase inhibitors (TKIs) in advanced NSCLC patients. 93
Cancer registry integration in the Umbria Regional Cancer Network: breast cancer as a model to build a supportive information system. 93
Linking surgical specimen length and examined lymph nodes in colorectal cancer patients 93
Dynamic network topologies analysis in proteomics data of NSCLC cell lines using a new pipeline based on machine learning tools 92
Seasonality of birth for skin melanoma deserves further investigation 91
High coexpression of both insulin-like growth factor receptor 1 (igfr-1) and epidermal growth factor receptor (egfr) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients 90
Epidemiology of HPV-related female cancers in the Umbria region of Italy: Pre-vaccination period 90
Italian cancer figures, report 2010: Cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients. 89
Use of Electronic Administrative Databases to Measure Quality Indicators of Breast Cancer Care: Experience of Five Regional Oncology Networks in Italy 89
Trends in invasive and in situ (CIN 3) cervical cancer incidence and mortality in Umbria, Italy: 1994-2008 88
I tumori del pene e del testicolo. 88
Numeri dell'AIRTUM: 2000 giovani italiani vivono con il cancro. 88
Staging, missing prognostic information and colorectal cancer control in Umbria 87
Geographical suite for web management system of cancer registries 87
La geografia del cancro in Umbria: incidenza 1978-2008. 87
Computational model of EGFR and IGF1R pathways in lung cancer: A Systems Biology approach for Translational Oncology (vol 30, pg 142, 2012) 87
Prevalence and spectrum of brca germline variants in central Italian high risk or familial breast/ovarian cancer patients: A monocentric study 87
Dynamic modeling, parameter estimation and experiment design in Systems Biology with applications to Oncology 86
I numeri di AIRTUM: Buone notizie per i bambini italiani. Dopo il 2000 si arresta anche la crescita dei tumori maligni del sistema nervoso centrale. 86
Narrative Medicine in Amyotrophic Lateral Sclerosis and a Rehabilitation Project Based on International Classification of Functioning, Disability and Health 86
I tumori della vescica. 86
Conditional robustness analysis for fragility discovery and target identification in biochemical networks and in cancer systems biology 85
Registro Tumori, tecnologia informatica e rete oncologica regionale: integrazione tra Registro Tumori e Servizi oncologici in Umbria. XIII Riunione annuale AIRTum. 84
Trend di incidenza e mortalità per cancro negli anziani in Umbria. 83
Dynamic modeling and parameter identification for biological networks: application to the DNA damage and repair processes 83
Clinical significances of ErbB family receptors, Myc, and mitogen-activated protein kinase (MAPK) in patients with early-stage non-small cell lung cancer. 82
Systems biology in personalized medicine in oncology: A case study in non-small cell lung cancer 81
Cancer and Pregnancy: Estimates in Italy from Record-Linkage Procedures between Cancer Registries and the Hospital Discharge Database 78
I tumori in Italia, rapporto 2011. La sopravvivenza dei pazienti oncologici in Italia. 76
What has changed in the epidemiology of skin melanoma in central Italy during the past 20 years? 74
Genome-wide expression of the residual lung reacting to experimental Pneumonectomy 74
Gruppo multidisciplinare regionale per le neoplasie tiroidee, registro tumori e tecnologia informatica: integrazione tra registro tumori e specialisti di oncologia tiroidea in Umbria. 70
INSULIN-LIKE GROWTH FACTOR RECEPTOR 1 (IGF1R) AND EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AMPLIFICATION AND EXPRESSION IN SURGICALLY RESECTED NSCLC 70
Seasonal variation in the month of birth in patients with skin cancer 70
Envelope stress response in E.Coli: computational model 69
Robustness of complex feedback systems: application to oncological biochemical networks 69
MYC and human telomerase (TERC) gene copy number gain in resected non-small cell lung cancer (NSCLC) 67
Systems Biology and translational oncology: a case study of predictive modeling in molecular biology of the lung cancer 66
Assessment of TILs, IDO-1 and PD-L1 in resected non small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications. 64
KRAS gene mutation testing an inter-laboratory validated workflow for quality assured, clinical-grade results using capillary electrophoresis. 64
Trend di mortalità per cause in Umbria. 1994-2010 64
SYSTEMS BIOLOGY IN TRANSLATIONAL ONCOLOGY: COMPUTATIONAL AND EXPERIMENTAL STUDY OF EGFR AND IGF1R PATHWAYS IN NSCLC CELL LINES 63
Espressione dei recettori Her nei carcinomi non a piccole cellule del polmone. 62
Estimates of cancer incidence to 2025 in Italy: Numbers and rates 60
Prognostic Role of Expression Levels of Fabp3, H19, Tfpi2, Akr1b10 Cyp3a5, Scgb3a2 Genes In Adenocarcinoma Stage I Patients 59
Influence of geographic barriers and care pathways on radiotherapy treatment and survival of breast cancer patients 58
Prognostic role of expression levels of FABP3 and AKR1B10 genes in adenocarcinoma stage I patients. 56
Trend d’incidenza delle lesioni cervicali in situ ed infiltranti in Umbria. 54
PROGNOSTIC AND PREDICTIVE ROLE OF PIK3CA MUTATIONS IN NON SMALL CELL LUNG CANCER PATIENTS TREATED WITH EGFR TYROSINE KINASE INHIBITORS (TKIS) 50
Totale 9.806
Categoria #
all - tutte 45.889
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.889


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022610 0 0 0 0 12 5 13 288 29 27 93 143
2022/20231.601 109 249 33 127 127 170 0 73 650 2 54 7
2023/2024600 35 54 27 23 4 5 151 26 66 16 107 86
2024/20251.279 33 121 106 34 157 62 41 99 235 72 207 112
2025/20262.974 211 190 159 412 440 248 462 142 299 271 99 41
2026/2027975 46 74 180 597 78 0 0 0 0 0 0 0
Totale 9.977